FCN-159
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for FCN-159, covering 2024-11-12 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors [Phase 2]